The role of patient-specific variables in protein corona formation and therapeutic efficacy in nanomedicine
Abstract Despite their potential, the adoption of nanotechnology in therapeutics remains limited, with only around eighty nanomedicines approved in the past 30 years. This disparity is partly due to the “one-size-fits-all” approach in medical design, which often overlooks patient-specific variables...
Saved in:
Main Authors: | Ethan P. Cisneros, Brinkley A. Morse, Ani Savk, Khyati Malik, Nicholas A. Peppas, Olivia L. Lanier |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-11-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-024-02954-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Nanomedicine and Nanotechnology in Dentistry – A Narrative Review
by: Richa Singh, et al.
Published: (2024-12-01) -
Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer
by: Yaqin Tang, et al.
Published: (2024-11-01) -
Nanomedicine for cancer patient‐centered care
by: Carlo Sorrentino, et al.
Published: (2024-11-01) -
Therapeutic Innovations in Nanomedicine: Exploring the Potential of Magnetotactic Bacteria and Bacterial Magnetosomes
by: Yadav VK, et al.
Published: (2025-01-01) -
The Protein Corona on Nanoparticles for Tumor Targeting in Prostate Cancer—A Review of the Literature and Experimental Trial Protocol
by: Giulio Bevilacqua, et al.
Published: (2024-12-01)